ITRM vs SPGI · rev $390.0K vs P/E 27, rev $15.34B
Iterum Therapeutics PLC (ITRM) versus S&P Global Inc (SPGI) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
ITRM currently screens at market cap $38.6M. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Not investment advice. Open the ITRM and SPGI stock pages for the full models.
Not investment advice.